CARDIO inCode-Score关于冠心病多基因风险的临床出版物。 CARDIO inCode-Score Clinical Publication on Polygenic Risk of Coronary Heart Disease.

GeninCode Plc 宣布在《美国预防心脏病学杂志》上发表一项研究。 GeninCode Plc announces the publication of a study in the American Journal of Preventive Cardiology. 该研究使用 CARDIO inCode-Score®，发现该评估工具可以从 63,000 名无冠心病病史的多民族成年人中识别出具有高冠心病 (CHD) 多基因风险的个体。 The study, using CARDIO inCode-Score®, found that the assessment tool can identify individuals with a high polygenic risk of Coronary Heart Disease (CHD) from a large, multiethnic cohort of 63,000 adults with no CHD history. 这项研究由凯撒医疗集团研究部进行，平均历时 14 年。 The study was conducted by the Kaiser Permanente Division of Research over an average of 14 years.